ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print February 20, 2008
Eur Respir J 2008, doi:10.1183/09031936.00116207
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Supplementary data
Right arrow All Versions of this Article:
31/6/1205    most recent
09031936.00116207v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manrique, H.A.
Right arrow Articles by Rodríguez-Roisin, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manrique, H.A.
Right arrow Articles by Rodríguez-Roisin, R.


ORIGINAL ARTICLE

Adenosine 5'-monophosphate in asthma: gas exchange and sputum cellular responses

H.A. Manrique 1, F.P. Gómez 1, P.A. Muñoz 1, A.M. Peña 1, J.A. Barberà 1, J. Roca 1, R. Rodríguez-Roisin 1*

1 Servei de Pneumologia (Institut del Tòrax), Hospital Clínic, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Ciber Enfermedades Respiratorias, Universitat de Barcelona, Barcelona, Spain

* To whom correspondence should be addressed. E-mail: rororo{at}clinic.ub.es.


   Abstract

Adenosine 5'-monophosphate (AMP) bronchoprovocation could reproduce the lung function abnormalities spontaneously occurring during acute asthma and detect peripheral airway inflammation better than direct bronchoconstrictive agents. Pulmonary gas exchange disturbances may reflect changes in small airways related to airway inflammation rather than bronchoconstriction alone.

We investigated whether AMP induces more ventilation-perfusion (VA/Q) imbalance than methacholine (MCh) at equivalent degree of bronchoconstriction with and without salbutamol pre-medication. We studied 36 asthmatics in three randomised, double-blinded, cross-over studies: before and after AMP/MCh (Study-1); and before and 30 min after salbutamol/placebo, followed by AMP (Study-2)/MCh (Study-3) challenge. Sputum was collected before and 4 h post-challenge.

Compared to MCh, AMP provoked similar pulmonary gas exchange abnormalities at an equivalent degree of intense bronchoconstriction (FEV1 fall, range 28–44%). While salbutamol blocked AMP/MCh-induced bronchoconstriction, PaO2 and AaPO2 disturbances were partially blocked (AMP, by 46% and 58%; MCh, by 42% and 57%, respectively). Compared to MCh, AMP increased neutrophils (from 28±17% to 38±16%, p<0.05) but not after salbutamol pre-treatment.

Both AMP and MCh induce similar peripheral airway dysfunction. The fully inhibited AMP-induced neutrophilia with residual hypoxaemia observed after salbutamol is likely related to beta-agonists acting on both bronchial and pulmonary circulations.

Keywords:  Direct and indirect bronchial challenges, induced sputum, multiple inert gas elimination technique, pulmonary gas exchange, short-acting bronchodilators




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
P. A. Munoz, F. P. Gomez, H. A. Manrique, J. Roca, J. A. Barbera, I. H. Young, S. D. Anderson, and R. Rodriguez-Roisin
Pulmonary gas exchange response to exercise- and mannitol-induced bronchoconstriction in mild asthma
J Appl Physiol, November 1, 2008; 105(5): 1477 - 1485.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the European Respiratory Society.